Risks cause FDA to take action

    by | Jun 12, 2017 | Health Across America

    The Washington Post has reported on June 9, 2017, that the Food and Drug Administration (FDA) has asked a drug company to remove its opioid pain medication from the market. The FDA has concluded that the medication, Opana ER, has risks that outweigh the benefits. This...